Journal of Clinical Endocrinology & Metabolism, Vol 62, 513-521, Copyright © 1986 by Endocrine Society

ARTICLES

The human fetal membranes: a target tissue for relaxin

ES Koay, GD Bryant-Greenwood, SY Yamamoto and FC Greenwood

The purpose of this study was to adduce further evidence for a paracrine role for human decidual relaxin (Rlx) in the remodelling of collagen in the fetal membranes in the peripartal period. The binding of [125I]porcine Rlx to membrane-enriched fractions from fetal membranes as well as from dispersed cells from the fetal membranes was used to demonstrate the presence of specific Rlx receptors. Rlx added in vitro to cultured amnion/chorion cells increased the release of plasminogen activator and collagenase into the medium. Rlx had no effect on the release of beta-glucuronidase. An in vivo correlate of these in vitro results was obtained, the detection of plasminogen activator and collagenase in amniotic fluids. The active fraction of collagenase was increased in amniotic fluids collected after spontaneous rupture of the membranes. PRL, hCG, estrogen, and progesterone added in equimolar amounts to cultured amnion/chorion cells from elective cesarean sections and normal term deliveries also effected the release of plasminogen activator and collagenase. The greatest effects were found in cells from cesarean section tissue, in terms of the stimulation of plasminogen activator release by Rlx and PRL and of collagenase release by prostaglandin F2 alpha and, to a lesser extent, by Rlx, PRL, and hCG. We conclude that human fetal membranes are targets for a number of hormones, including the decidual paracrine hormones Rlx, PRL, and prostaglandin F2 alpha as well as estrogen, progesterone, and hCG. These hormones act to release or inhibit the enzymes involved in collagen breakdown before rupture of the fetal membranes.

This article has been cited by other articles:

				R. A. Bathgate, R. Ivell, B. M. Sanborn, O. D. Sherwood, and R. J. Summers International Union of Pharmacology LVII: Recommendations for the Nomenclature of Receptors for Relaxin Family Peptides. Pharmacol. Rev., March 1, 2006; 58(1): 7 - 31. [Abstract] [Full Text] [PDF]

				J. A. Lenhart, P. L. Ryan, K. M. Ohleth, S. S. Palmer, and C. A. Bagnell Relaxin Increases Secretion of Matrix Metalloproteinase-2 and Matrix Metalloproteinase-9 during Uterine and Cervical Growth and Remodeling in the Pig Endocrinology, September 1, 2001; 142(9): 3941 - 3949. [Abstract] [Full Text] [PDF]

				S. Hombach-Klonisch, S. Seeger, G. Tscheudschilsuren, J. Buchmann, B. Huppertz, G. Seliger, B. Fischer, and T. Klonisch Cellular localization of human relaxin-like factor in the cyclic endometrium and placenta Mol. Hum. Reprod., April 1, 2001; 7(4): 349 - 356. [Abstract] [Full Text] [PDF]

				J. McLaren, D.J. Taylor, and S.C. Bell Prostaglandin E2-dependent production of latent matrix metalloproteinase-9 in cultures of human fetal membranes Mol. Hum. Reprod., November 1, 2000; 6(11): 1033 - 1040. [Abstract] [Full Text] [PDF]

				L. S. TASHIMA, L. K. MILLAR, and G. D. BRYANT-GREENWOOD Genes Upregulated in Human Fetal Membranes by Infection or Labor Obstet. Gynecol., September 1, 1999; 94(3): 441 - 449. [Abstract] [Full Text] [PDF]

				R. L. Jones, H. O. D. Critchley, J. Brooks, H. N. Jabbour, and A. S. McNeilly Localization and Temporal Expression of Prolactin Receptor in Human Endometrium J. Clin. Endocrinol. Metab., January 1, 1998; 83(1): 258 - 262. [Abstract] [Full Text]